It is, once again, that time of year: All the property tax bills for 2025 have been sent out to Milwaukee property owners and are available online, the City Treasurer's Office said in a Dec. 12 news ...

AT&T has agreed to a $177 million settlement for class action lawsuits over multiple data breaches in 2024. Customers whose personal information was exposed could be eligible for payments totaling up ...

From spreading out payments to dodging impulse purchases, holiday shoppers this year took a more judicious approach to spending over the Black Friday-Cyber Monday sales weekend, data shows.

Eli Lilly & Co. is cutting the price for introductory doses of its weight-loss drug Zepbound again, as competition heats up with rival Novo Nordisk A/S. Starting Monday, the lowest dose vial will cost ...

Small business Saturday is just around the corner, and some businesses are telling shoppers the best gift for them is cash. Paying with cash would help businesses offset credit card processing fees ...

At a time when several highly-publicized class-action lawsuits have accused employers of overpaying for prescription drugs whose costs keep rising, the Rx benefits landscape may look daunting. But ...

Ohio lawmakers are considering a proposal that would force businesses and government offices across the state to accept cash — a move supporters say protects consumers who don’t want to rely on ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Northeastern University's cash ...

In a virtual fireside chat on Tuesday with Scripta Insights CEO Eric Levin, Mark Cuban spoke passionately about the potential of simplified contracting and cash pay. Scripta is a partner of Cuban’s ...

Novo Nordisk A/S is undercutting arch-rival Eli Lilly & Co. on obesity drugs for cash-pay patients, showing its willingness to compete on price as it tries to claw back a larger share of the US market ...

Days after joining its fellow GLP-1 giant Eli Lilly in coming to agreements with the Trump administration to slash the costs of their uber popular weight loss meds in the U.S., Novo Nordisk has pulled ...